financing
Helix Raises $50M in Series C Financing
The company plans to use the new funding to accelerate the use of its population genomics platform and to support its COVID-19 testing and viral surveillance efforts.
Clear Labs Raises $60M in Series C Financing Round
The funds will be used to help broaden the availability of the company's solutions to identify and trace all strains of pathogens, such as SARS-CoV-2.
Caris Life Sciences Raises $830M to Support Precision Medicine Platform, Liquid Biopsy Development
The funds will help support Caris' ongoing commercial efforts in comprehensive cancer genomics as it makes new forays into liquid biopsy for multi-cancer early detection.
Oxford Nanopore Technologies Raises £195M
In late March, the nanopore sequencing firm said it plans an initial public offering on the London Stock Exchange later this year.
Genome Editing Company EdiGene Raises RMB 400M in Series B Plus Financing Round
The Beijing-headquartered company will use the proceeds to advance its pipeline of genome editing technologies into clinics and to scale up business operations.